TGFB1 and neoplasm: Indeed, the release of factors such as PDGF, TGF-β, FGF, and MMPs by tumor or stromal cells induces fibroblasts to acquire contractile capacities and to express specific markers such as α-SMA, FAP, and FSP, characteristic of the activated phenotype [2].